Koers Miravant Medical Technologies Inc. Other OTC
Aandelen
MRVT
US6046901079
Biotechnologie & Medisch Onderzoek
Omzet 2003 | - | Omzet 2004 | - | Marktkapitalisatie | 36,86 mln. 34,56 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2003 | -7 mln. -6,56 mln. | Nettowinst (verlies) 2004 | -15 mln. -14,06 mln. | EV/omzet 2003 | - |
Nettoschuld 2003 | 11,89 mln. 11,14 mln. | Nettoschuld 2004 | 4,22 mln. 3,95 mln. | EV/omzet 2004 | - |
K/w-verhouding 2003 |
-4,24
x | K/w-verhouding 2004 |
-2,1
x | Werknemers | - |
Dividendrendement 2003 * |
-
| Dividendrendement 2004 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-10,19% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |